Sequential ctDNA whole-exome sequencing in advanced lung adenocarcinoma with initial durable tumor response on immune checkpoint inhibitor and late progression

BACKGROUND: Despite prolonged tumor response to immune checkpoint inhibitors (ICIs) for a subset of patients with advanced non-small cell lung cancer (NSCLC), a secondary resistance will occur for a majority of these patients. The understanding of late progression mechanisms with ICIs is important t...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Immunother Cancer
Главные авторы: Giroux Leprieur, Etienne, Hélias-Rodzewicz, Zofia, Takam Kamga, Paul, Costantini, Adrien, Julie, Catherine, Corjon, Alexandre, Dumenil, Coraline, Dumoulin, Jennifer, Giraud, Violaine, Labrune, Sylvie, Garinet, Simon, Chinet, Thierry, Emile, Jean-François
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Publishing Group 2020
Предметы:
Clinical/Translational Cancer Immunotherapy
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7319709/
https://ncbi.nlm.nih.gov/pubmed/32581058
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000527
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы